GSN and myeloid sarcoma: During MS, axonal degeneration leads to a release of actin within the CNS, which may mobilize gelsolin from plasma to CNS [50], as demonstrated by studies showing low levels of gelsolin in blood and in CSF of MS patients [50], [51].